Stockreport

BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024

BioAtla, Inc.  (BCAB) 
PDF SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Ac [Read more]